Mark Artherton, CFA

Inteqres

Thematic (Sector/Industry)

<p>We dissect the recent decline across Asia and emerging markets with the aim of identifying a few interesting areas for managers to utilise cash.   The suggestions are both short and long term.  This first note looks at the markets from a sectoral viewpoint.  We identify a few banks, healthcare and tech companies worthy of investor attention.</p>

We dissect the recent decline across Asia and emerging markets with the aim of identifying a few interesting areas for managers to utilise cash.   The suggestions are both short and long term.  This first note looks at the markets from a sectoral viewpoint.  We identify a few banks, healthcare and tech companies worthy of investor attention.

Covid-19 - We Identify Some Opportunities in Markets - Inteqres Review

Chief Economist

Diana Choyleva

Enodo Economics

Enodo Economics is an independent macroeconomic forecasting company that untangles complexity, challenges the consensus, and makes sense of the future. Our focus is on China – one of the most misunderstood economies in the world, but one of the most important to figure out.  Enodo’s chief economist, Diana Choyleva, has been analysing China for almost 20 years, while Enodo’s team boasts a combined 140 years’ experience covering China’s economy, politics and markets. 

Macroeconomics

<h2><strong>China News That Matters</strong></h2><ul><li>PBOC eases monetary policy</li><li>Markets told to keep calm and carry on</li><li>More trade war talks</li><li>Lukewarm ‘tech’ IPO for Xiaomi</li><li>China rebalancing through tax relief</li><li>World Cup fever</li></ul><div class="content-remarks"><p>In my weekly digest China News That Matters, I will give you selected summaries, sourced from a variety of local Chinese-language and international news outlets, and highlight why I think the news is significant. These posts are meant to neither be bullish nor bearish, but help you separate the signal from the noise.</p></div>

China News That MattersPBOC eases monetary policyMarkets told to keep calm and carry onMore trade war talksLukewarm ‘tech’ IPO for XiaomiChina rebalancing through tax reliefWorld Cup feverIn my weekly digest China News That Matters, I will give you selected summaries, sourced from a variety of local Chinese-language and international news outlets, and highlight why I think the news is significant. These posts are meant to neither be bullish nor bearish, but help you separate the signal from the noise.

PBoC Easing/2015 Déjà Vu/ China-US Trade War Intensifies/Xiaomi Flop/Consumer Bonus

HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Equity Capital Markets

Good Doctor Cloud Healthcare & Technology Group / Equity Capital Markets

Good Doctor Cloud Healthcare & Technology Group (GDC HK)

Good Doctor Cloud Healthcare & Technology Group

<ul>
<li>The business model of GOOD DOCTOR CLOUD (CDC) is more of a “middleman”, so its profits is largely dependent on the “price difference” and continuous expansion of customer base.</li>
<li>Short-Term strong demand brought by COVID-19 won’t last. If customer growth fails to meet expectations, long-term performance growth will gradually decline, and even lead to the recurrence of losses.</li>
<li>Although CDC has turned losses into profits, the current earnings are still unstable. Therefore, we suggest using the P/S ratio for valuation, which should be lower than peers.</li>
</ul>


The business model of GOOD DOCTOR CLOUD (CDC) is more of a “middleman”, so its profits is largely dependent on the “price difference” and continuous expansion of customer base.
Short-Term strong demand brought by COVID-19 won’t last. If customer growth fails to meet expectations, long-term performance growth will gradually decline, and even lead to the recurrence of losses.
Although CDC has turned losses into profits, the current earnings are still unstable. Therefore, we suggest using the P/S ratio for valuation, which should be lower than peers.


Pre-IPO Good Doctor Cloud Healthcare & Technology Group - Pain Points of Business Models and Outlook

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of December 19th.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight flows for Xiaomi, Meituan, Alibaba, Ping An Insurance, Ke, China Mobile, Hua Hong Semiconductor, Petrochina, SMIC, HKEx.</li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine for holding position as of December 19th.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight flows for Xiaomi, Meituan, Alibaba, Ping An Insurance, Ke, China Mobile, Hua Hong Semiconductor, Petrochina, SMIC, HKEx.


HK Connect Flows Weekly (Dec 19th): Xiaomi, Meituan, Alibaba, Ping An Insurance, Ke, China Mobile

Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Periscope Analytics

Periscope Analytics focuses on event-driven trades across Asia Pacific and provides comprehensive, timely and systematic coverage of index changes to major Asia Pacific indices in a structured manner.

The analysis includes forecasted inclusions and exclusions to all major Asian indices that have significant amount of tracking assets, including estimates of passive buy/sell flow on the stocks. The service also provides commentary and impact of market consultations, ground rule changes, and other events (IPOs, spin-offs, M&A) that could lead to index changes and passive flow.

Periscope Analytics works with multi-strategy hedge funds, proprietary trading firms, stat arb trading groups and long-only investors that invest and trade in the Asia Pacific region with the data being used to trade index rebalances, avoid pre-positioning and passive flow, and to time entry into and exit from stocks.

Event-Driven Trades Across Asia Pacific

Index Rebalance

<ul>
<li>The December rebalance of the <a href="https://www.smartkarma.com/entities/kraneshares-csi-china-internet-etf" target="_blank" data-smartkarma-citation="entities:28208:1" rel="noopener">KraneShares CSI China Internet ETF (KWEB US)</a> will take place at the close of trading on 12 December.</li>
<li>
<a href="https://www.smartkarma.com/entities/alibaba-pictures-group-ltd" target="_blank" data-smartkarma-citation="entities:20724:1" rel="noopener">Alibaba Pictures</a>, <a href="https://www.smartkarma.com/entities/east-buy-holding-ltd" target="_blank" data-smartkarma-citation="entities:27796:1" rel="noopener">East Buy Holding</a>, <a href="https://www.smartkarma.com/entities/ping-an-healthcare-and-technology-company-limited" target="_blank" data-smartkarma-citation="entities:27008:1" rel="noopener">Ping An Healthcare and Technology</a>, <a href="https://www.smartkarma.com/entities/xd-inc" target="_blank" data-smartkarma-citation="entities:28283:1" rel="noopener">XD Inc.</a> and <a href="https://www.smartkarma.com/entities/caocao-inc" target="_blank" data-smartkarma-citation="entities:42803:1" rel="noopener">CaoCao (2643 HK)</a> will be added, while <a href="https://www.smartkarma.com/entities/iqiyi-inc" target="_blank" data-smartkarma-citation="entities:26755:1" rel="noopener">iQIYI Inc (IQ US)</a> will be deleted.</li>
<li>Short interest has increased in most adds recently and there could be some short covering following the announcement of the index inclusion.</li>
</ul>


The December rebalance of the KraneShares CSI China Internet ETF (KWEB US) will take place at the close of trading on 12 December.

Alibaba Pictures, East Buy Holding, Ping An Healthcare and Technology, XD Inc. and CaoCao (2643 HK) will be added, while iQIYI Inc (IQ US) will be deleted.
Short interest has increased in most adds recently and there could be some short covering following the announcement of the index inclusion.


China

Ping An Healthcare and Technology Company Limited operates an online healthcare services platform in China, offering online consultations, hospital referrals, health management, and wellness services. The company provides a range of services including online diagnosis and treatment, health check-ups, and drug delivery through its mobile platform. It was founded in 2014 and is headquartered in Shanghai, China.

Ping An Healthcare and Technology (1833 HK)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Ping An Healthcare and Technology (1833 HK)

Covid-19 - We Identify Some Opportunities in Markets - Inteqres Review

We dissect the recent decline across Asia and emerging markets with the aim of identifying a few interesting areas for managers to utilise cash. ...

Mark Artherton, CFA

PBoC Easing/2015 Déjà Vu/ China-US Trade War Intensifies/Xiaomi Flop/Consumer Bonus

China News That Matters PBOC eases monetary policy Markets told to keep calm and carry on More trade war talks Lukewarm ‘tech’ IPO for Xiaomi China...

Diana Choyleva

Pre-IPO Good Doctor Cloud Healthcare & Technology Group - Pain Points of Business Models and Outlook

GOOD DOCTOR CLOUD's profits rely on price difference/customer base growth.Short-term high growth won't last.Long-term success hinges on meeting...

Xinyao (Criss) Wang

HK Connect Flows Weekly (Dec 19th): Xiaomi, Meituan, Alibaba, Ping An Insurance, Ke, China Mobile

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Xiaomi, Meituan, Alibaba, Ping An Insurance, Ke, China...

Ke Yan, CFA, FRM

KWEB Index Rebalance: 5 Adds & A Delete

There are 5 adds and 1 delete for the KWEB ETF in Dec. Most of the changes were forecast but short covering and positioning could take the stocks...

Brian Freitas

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Covid-19 - We Identify Some Opportunities in Markets - Inteqres Review

We dissect the recent decline across Asia and emerging markets with the aim of identifying a few interesting areas for managers to utilise cash. ...

Mark Artherton, CFA

PBoC Easing/2015 Déjà Vu/ China-US Trade War Intensifies/Xiaomi Flop/Consumer Bonus

China News That Matters PBOC eases monetary policy Markets told to keep calm and carry on More trade war talks Lukewarm ‘tech’ IPO for Xiaomi China...

Diana Choyleva

Pre-IPO Good Doctor Cloud Healthcare & Technology Group - Pain Points of Business Models and Outlook

​GOOD DOCTOR CLOUD's profits rely on price difference/customer base growth.Short-term high growth won't last.Long-term success hinges on meeting...

Xinyao (Criss) Wang

HK Connect Flows Weekly (Dec 19th): Xiaomi, Meituan, Alibaba, Ping An Insurance, Ke, China Mobile

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Xiaomi, Meituan, Alibaba, Ping An Insurance, Ke, China...

Ke Yan, CFA, FRM

KWEB Index Rebalance: 5 Adds & A Delete

There are 5 adds and 1 delete for the KWEB ETF in Dec. Most of the changes were forecast but short covering and positioning could take the stocks...

Brian Freitas

GOOD DOCTOR CLOUD's profits rely on price difference/customer base growth.Short-term high growth won't last.Long-term success hinges on meeting...